Antimutagenic activity of lutein -an oxycarotenoid present in the macula and its inhibition of cytochrome P 450 enzymes in vitro

Drug Metabolism Letters

Volumn 6, Issue 3, 2012, Pages 213-220

  Sindhu, Edakkadath R ^a   Firdous, Alikkunjhi P ^a   Viswanathan, Ramnath ^b   Kuttan, Ramadasan ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

^b Kerala Veterinary and Animal Sciences University   (India)

Author keywords

Ames test; Antimutagenicity; Cytochrome P450 enzymes; Salmonella typhimurium

Indexed keywords

ANTIOXIDANT; CYTOCHROME P450; DRUG METABOLIZING ENZYME; METHYLNITRONITROSOGUANIDINE; MUTAGENIC AGENT; N (2 FLUORENYL)ACETAMIDE; SODIUM AZIDE; XANTHOPHYLL;

AMES TEST; ANIMAL EXPERIMENT; ANTIMUTAGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHEMICAL STRUCTURE; DRUG ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM; TOBACCO; TOXICITY;

ANIMALS; ANTIMUTAGENIC AGENTS; ANTIOXIDANTS; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; LUTEIN; MACULA LUTEA; MALE; MUTAGENS; RATS; RATS, WISTAR; SALMONELLA TYPHIMURIUM;

NICOTIANA TABACUM; SALMONELLA TYPHIMURIUM;

EID: 84876730531     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872312811206030009     Document Type: Article

References (32)

1. De Flora, S.; Izzotti, A.; Randerath, K.; Randerath, E.; Lertas, J. DNA adducts in chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat. Res., 1996, 366, 197-238.
2. Archer, M.C. Mechanisms of action of N-nitroso compounds. Cancer Survey, 1989, 8(2), 241-50.
3. Vitaglione, P.; Morisco, F.; Caporaso, N.; Fogliano, V. Dietary antioxidant compounds and liver health. Crit. Rev. Food Sci. Nutr. 2004, 44, 575-86.
4. Mortelmans, K.; Zeiger, E. The Ames Salmonella/ micrsome mtagenicity assay, Mutat. Res., 2000, 445, 29-60.
5. Ames, B.N.; McCann, J.; Yamasaki, E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutat. Res., 1975, 31, 347-64.
6. Johnson, E.J. The role of carotenoids in human health. Nutr. Clin. Care, 2002, 5, 56-65.
7. Flag, E.W.; Coates, R.J.; Greenberg, R.S. Epidemiological studies of antioxidants and cancer in humans. J. Am. Coll. Nutr., 1995, 14, 419-27.
8. Park, J.S.; Chew, B.P.; Wong, T.S. Dietary lutein from marigold extract inhibits mammory tumor development in Balb/c mice. J. Nutr., 1998, 128, 1650-56.
9. Khachik, F.; Beecher, G.R.; Smith, J.C. Lutein lycopene and their oxidative metabolites in cancer prevention of cancer. J. Cell Biochem., 1995, 22, 236-46.
10. Sindhu, E.R.; Preethi, K.C.; Kuttan, R. Antioxidant activity of carotenoid lutein in vitro and in vivo. Indian J. Exp. Biol., 2010, 48, 843-48.
11. Moron, D.M.; Ames, B.N. Revised methods for salmonella mutagenicity test. Mutat. Res., 1983, 113, 173-215.
12. Garner, R.C.; Miller, E.C.; Miller, J.A. Liver microsomal metabolism of aflatoxin B1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res., 1972, 32, 2058-66.
13. Sukumaran, K.; Kuttan, R. Inhibition of tobacco-induced mutagenesis by eugenol and plant extracts. Mutat. Res., 1995, 343, 25-30.
14. Firdous, A.P.; Sindhu, E.R; Ramnath, V.; Kuttan, R. Anti-mutagenic and anti-carcinogenicity of the carotenoid meso-Zeaxanthin. Asian Pac. J. Cancer Prev., 2010, 11, 1-6.
15. Pohl, R.J; Fouts, J.R. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions, Anal. Biochem., 1980, 107, 150-55.
16. Nerurkar, P.V.; Park, S.S.; Thomas, P.E. Methoxy resorufin and benzyloxyresorufin: substrates preferentially metabolized by cyt P450 1A2 and 2B, respectively in the rat and mouse. Biochem. Pharmacol., 1993, 46, 933-44.
17. Lowry, O.H.; Rosenbrough, N.J; Farr, A.L.; Randall, J. Protein measurement with Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-75.
18. Mazel, P. Experiments illustrating drug metabolism in vitro., in: La Duq B.N, Mandel H.G, Way E.L (Eds.), Fundamentals of drug metabolism and drug disposition, Williams and Wilkins, Baltimore, 1971, pp. 546-78.
19. Michaud, D.S.; Feskanich, D.; Rimm, E.B.; Colditz, G.A.; Speizer, F.E.; Willett, W.C; Giovannucci, E. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am. J. Clin. Nutr., 2000, 72, 990-97.
20. Isono, K.; Yourno, J. Chemical carcinogens as frame shift mutagens: Salmonella DNA sequence sensitive to mutagenesis by polycyclic carcinogens. Proc. Natl. Acad. Sci. U.S.A., 1974, 71, 1612-1617.
21. Barnes, W.; Tuley, E.; Eisenstadt, E. Base-sequence analysis of HisC revertants of the hiG46 missense mutation in Salmonella typhimurium. Environ. Mutagen., 1982, 4, 297.
22. Duncan, H.M.; Mackler, B. Electron transport systems of yeast. 3. Preparation and properties of cytochrome oxidase. J. Biol. Chem., 1966, 241, 1694-1697.
23. Koch, W.H.; Henrikson, E.N.; Kupchella, E.; Cebula, T.A. Salmonella typhimurium strain TA 100 differentiates several classes of carcinogens and mutagens by base substitution specificity. Carcinogenesis, 1994, 15, 79-88.
24. Beranek, D.T., Weis, C.C.; Swenson, D.H. A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis, 1980, 1, 595-606.
25. Schrenk, D.; Gant, T.W.; Michalke, A.; Orzechowski, A.; Silverman, J.A.; Battula, N.; Thorgeirsson, S.S. Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis, 1994, 15, 2541-2546.
26. Plewa, M.J.; Smith, S.R.; Wagner, E.D. Diethyldithiocarbamite suppresses the plant activated aromatic amines by inhibiting tobacco cell peroxidase. Mutat. Res., 1991, 247, 47-64.
27. Bagchi, K.; Puri, S. Free radicals and antioxidants in health and disease. East. Mediterr. Health J., 1998, 4, 350-360.
28. Miki, W. Biological functions and activities of animal carotenoids. Pure Appl. Chem., 1991, 61, 141-46.
29. Conney, A.H. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture. Cancer Res., 2003, 63, 7005-7031.
30. Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L. Jr, Valanis B, Williams, J.H. Jr.; Barnhart, S.; Cherniack, M.G.; Brodkin, C.A.; Hammer, S. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and retinol efficacy trial. J. Natl. Cancer Inst., 1996, 88, 1550-1559.
31. Black, S.H. Pro-oxidant and anti-oxidant mechanism(s) of BHT and ß-carotene in photocarcinogenesis. Front Biosci., 2002, 7, 1044-55.
32. Sindhu, E.R.; Firdous, A.P.; Preethi, K.C.; Kuttan, R. Carotenoids lutein protects rats from paracetamol, carbon tetra chloride and ethanol induced hepatic damage. J. Pharm. Pharmacol., 2010, 62, 1054-60.